Empower Clinics Inc.
21.7.2021 10:37:39 CEST | ACCESS Newswire | Press release
Exclusive non-binding term sheet signed to allow Empower to fully divest of its cannabis businesses
VANCOUVER, BC / ACCESSWIRE / July 21, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - The company has received and signed a non-binding term sheet to enter into an agreement that would allow Empower to divest of its legacy cannabis assets and fully focus on its integrated healthcare business.
The associated non-binding agreement outlines that Andrea Klein and Dustin Klein (together the "Kleins") will acquire 100% of Sun Valley Health Holdings LLC, Sun Valley Health Franchising, LLC, Sun Valley Health, LLC, Sun Valley Health West, LLC, Sun Valley Health Tucson, LLC, Sun Valley Health Mesa, LLC, Sun Valley Alternative Health Centers NV, LLC, and all subsidiaries thereof (together "Sun Valley").
"This transaction will allow Empower to complete the divestment of its legacy cannabis assets and focus on its integrated healthcare vision", said Steven McAuley. "We also expect this divestment to allow Empower to engage with a different breadth of partners - such as banks, auditors and advertising companies - who had restrictions against engaging companies in the cannabis space".
The structure of the agreement is on a cash-free, debt-free basis wherein the consideration of $1,000,000 USD, is to be settled by the transfer from the Kleins to, or as directed by, the Seller, of such number of common shares in the capital of Empower (each, a "Share") as is equal to $1,000,000 USD divided by the United States dollar equivalent (based on the Bank of Canada daily exchange rate for the conversion of Canadian dollars to United States dollars on the applicable date) of the volume weighted average trading price of the Shares on the Canadian Securities Exchange (the "CSE") for the 10 trading days ending on the date that is two business days prior to the date of closing of the Acquisition (collectively, the "Consideration Shares").
Completion of the transaction is subject to customary closing conditions, including completion of due diligence, negotiation of definitive agreements and receipt of all necessary approvals. If such conditions are not satisfied it is possible that the proposed transaction will not be completed on the terms set forth herein or at all. The parties anticipate completing the definitive agreements within the next 30 to 60 days.
This non-binding transaction will permit Empower to robustly pursue its integrated health plan through initiatives such as the national clinic expansion and Kai Care Testing Solutions, along with an aggressive acquisition strategy.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley's franchise model; launch of new healthcare centers and the occurrence thereof; that the Company can bring healthcare to millions of Canadians; that new healthcare services can be added and that the Company will be positioned to be a market- leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that Kai Medical Laboratory will successfully win any US Government RFP; that the MedX Health pilot program will be successful; that Empower will place the MedX Health teledermatology product in health centers in North America; that the Company's products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for Canadian clinics or Kai Medical Laboratory expansion inn 2Q 2021; that the sale of Sun Valley will close as anticipated; that general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
SOURCE: Empower Clinics Inc.
View source version on accesswire.com:
https://www.accesswire.com/656437/Empower-Announces-Sale-of-Its-Cannabis-Related-Assets
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 20262.4.2026 18:32:00 CEST | Press release
PHILADELPHIA, PA / ACCESS Newswire / April 2, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that CEO Nathaniel (Nate) T. Bradley will present and exhibit the Company's DataValue®, DataScore®, Data Vault Bank® AI Agent, and patented Information Data Exchange® technologies at XRP Tokyo 2026 on April 7, 2026, at Happo-en in Tokyo, Japan. Bradley's presentation, "Data-Driven RWA Tokenization: Unlocking Japan's Trillion-Yen Opportunity on the XRP Ledger," will demonstrate how Datavault AI's platforms support secure, AI-powered tokenization of real estate, commodities, and other high-value assets in Japan's regulation-friendly market. Japan has emerged as Asia's leading real-world asset tokenization market, with institutional platforms such as Progmat (MUFG-backed) managing approximately ¥440 billion (~$2.8 billion USD) in token
Valsoft Corporation Strengthens Its Retail Software Portfolio with the Acquisition of NedFox2.4.2026 15:00:00 CEST | Press release
MONTRÉAL, QC / ACCESS Newswire / April 2, 2026 / Valsoft Corporation Inc. ("Valsoft"), a Montreal-based company specializing in the acquisition and development of vertical market software businesses, is pleased to announce the acquisition of NedFox, the Netherlands-based software producer of RetailVista, a comprehensive Retail ERP platform designed to support modern retail operations. Headquartered in the Netherlands, NedFox develops and markets RetailVista, an integrated cloud-based Retail ERP solution that enables retailers to manage point-of-sale, inventory, purchasing, financial administration, and reporting within a unified environment. With a strong focus on continuous innovation and customer-driven development, NedFox has built a reputation for delivering reliable, scalable software tailored to the evolving needs of retail businesses. "NedFox has built a robust and highly regarded Retail ERP platform with RetailVista, supported by a passionate team and a strong customer focus,"
Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care2.4.2026 14:10:00 CEST | Press release
Gedeon Richter's Side-by-Side Conference on Advancing Women's Health brought together Healthcare practitioners from 40 countries for a dynamic two-day exchange on March 26-27, making it the largest event of its kind ever organized by the company. BUDAPEST, HU / ACCESS Newswire / April 2, 2026 / Developed in collaboration with internationally recognized experts and grounded in peer-reviewed data, the program provided evidence-based updates on recent advances and innovations across key therapeutic areas, underscoring scientific integrity and evidence-based discussions. Beyond the science, the conference brought into focus how effective communication between healthcare professionals and patients can lead to improved diagnostic accuracy, treatment adherence, and overall patient satisfaction, as emphasized during his keynote lecture by Sukhbir Sony Singh, Full Professor and Chair of the Department of Obstetrics and Gynecology at the University of Ottawa. Day 1 focused on endometriosis and u
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo2.4.2026 13:00:00 CEST | Press release
DI Women's and Men's Finals to be Featured in ‘Breakaway: Polo in College' on ESPN WEST PALM BEACH, FLA. / ACCESS Newswire / April 2, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly supported the Division I National Intercollegiate Championship (NIC), held March 19-22, 2026, near Dallas, Texas, at the Prestonwood Polo & Country Club. As the highest level of collegiate polo in the United States, the NIC brings together the nation's top student-athletes to compete for national titles.2026 Division I Women's National Intercollegiate Champions, University of South Carolina - Aiken Polo Team Winifred Branscum, Madison Jordan, and Brianna Jordan; 2026 Division I Men's National Intercollegiate Champions, University of North Texas Polo Team Alec Felhaber, Niklaus Felhaber, Johann Felhaber, Mosiah Gravesande, Sebastian Celis Guerrero Photo Credit: @oanaphoto As a proud supporter of the USPA's Intercollegiate/Interscholastic (I/I) Program,
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform1.4.2026 17:50:00 CEST | Press release
DVLT × Demora Foundation: Datavault AI's Enterprise AI Stack Deployed as the Data Intelligence & RWA Tokenization Layer for K-Pop, K-Drama, K-Entertainment, and K-Culture IP - Serving 200M+ Hallyu Fans Across 156 Countries Through K2Global's 500+ Korean SMB Network and Three US Innovation K-Wave Cities PHILADELPHIA, PA AND WILMINGTON, DE / ACCESS Newswire / April 1, 2026 / Datavault AI Inc. (NASDAQ:DVLT), an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company, and Demora Foundation, the Delaware-incorporated governing organization of the Demora Chain ecosystem (governed under JP3E Holdings Inc.), today announced the execution of a Technology Integration Agreement establishing Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform - the integrated K2Global + Demora Foundation ecosystem that converts Korean cultural IP, live entertainment, and K-Wave soft power into institution
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
